Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative oncology treatments. The company leverages its scientific expertise to develop novel immunotherapies and cancer therapeutics aimed at improving patient outcomes. By combining a robust clinical pipeline with commercialized therapeutic products, Coherus strives to address significant unmet medical needs in cancer care while expanding its operational footprint across the biopharmaceutical landscape.